Efficacy and safety of sacubitril valsartan in heart failure compared to renin angiotensin aldosterone system inhibitors: a systematic review and meta analysis of randomised controlled trials

26 August 2022 (15:15 - 16:00)
Organised by:
Congress Presentation Part of: Heart failure pharmacotherapy - Sacubitril/valsartan Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by